Xenetic Biosciences Ownership | Who Owns Xenetic Biosciences?
Xenetic Biosciences Ownership Summary
Xenetic Biosciences is owned by 3.80% institutional investors, and 96.20% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.64% of its assets in Xenetic Biosciences shares.
XBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xenetic Biosciences | 3.80% | - | 96.20% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | 18 | - | 576,596 | -16.89% | 3 | 18.17% | 4 | -60.00% | 7 | 133.33% |
| Dec 31, 2022 | 18 | 38.46% | 693,755 | -30.09% | 4 | 10.68% | 10 | 233.33% | 3 | - |
| Sep 30, 2022 | 13 | 8.33% | 992,384 | -4.08% | 6 | 14.06% | 3 | -40.00% | 3 | 50.00% |
| Jun 30, 2022 | 12 | -7.69% | 1,034,614 | -1.15% | 6 | 14.32% | 5 | 25.00% | 2 | -33.33% |
| Mar 31, 2022 | 13 | -35.00% | 1,046,598 | -28.20% | 6 | 7.47% | 4 | -63.64% | 3 | -25.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 9.80K | 0.64% | - |
| Fidelity Extended Market Index | 7.58K | 0.49% | -50.00 |
| Fidelity Nasdaq Composite Index | 2.07K | 0.13% | - |
| Fidelity Series Total Market Index | 1.82K | 0.12% | - |
| NT Ext Equity Mkt Idx Fd - NL | 1.02K | 0.07% | - |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 805.00 | 0.05% | -13.00 |
| NT Ext Equity Mkt Idx Fd - L | 761.00 | 0.05% | - |
| Northern Trust Extended Eq Market Idx | 761.00 | 0.05% | - |
| SSgA U.S. Extended Market Index Class I | 390.00 | 0.03% | - |
| State St US Extended Mkt Indx NL Cl C | 390.00 | 0.03% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2023 Q4 | - | - |
| 2022 Q4 | - | - |
| 2022 Q1 | - | - |
| 2021 Q4 | - | - |
XBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools